Human Receptor-type tyrosine-protein phosphatase C 1227-1237, STYPAQNGQVK
Description
About Human Receptor-type tyrosine-protein phosphatase C 1227-1237, STYPAQNGQVK
The Human Receptor-type tyrosine-protein phosphatase C Peptide (IEDB: 163553) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Receptor-type tyrosine-protein phosphatase Peptide, H-STYPAQNGQVK-OH (Uniprot: P08575 aa: 1227-1237) from JPT is produced under strict quality control and quality management.
Human Receptor-type tyrosine-protein phosphatase C 1227-1237, STYPAQNGQVK - Specifications
- Peptide sequence: H-STYPAQNGQVK-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Leukemia
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Receptor-type tyrosine-protein phosphatase C 1227-1237, STYPAQNGQVK
References:
Read References with JPT’s Antigen Peptides
Human Receptor-type tyrosine-protein phosphatase C 1227-1237, STYPAQNGQVK has been described in:
MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements, nan, 2012 (PMID: Submission)
Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides., Nat Commun, 2014 (PMID: 24714562)
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases., Cell Rep Med, 2021 (PMID: 33521695)
Documentation
Documentation for Human Receptor-type tyrosine-protein phosphatase C 1227-1237, STYPAQNGQVK
Properties
Properties of Human Receptor-type tyrosine-protein phosphatase C 1227-1237, STYPAQNGQVK
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Leukemia |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Receptor-type tyrosine-protein phosphatase |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Receptor-type tyrosine-protein phosphatase C 1227-1237, STYPAQNGQVK
Information | Values |
---|---|
Sequence: | H-STYPAQNGQVK-OH |
Specifications: | 11mer peptide as TFA salt |